(Press-News.org) Researchers looking to help people suffering from addiction, depression, and pain are studying how certain brain neurons operate to see if they can be controlled.
In a paper published May 11 in Neuron, researchers at the University of Washington School of Medicine and Washington University in St. Louis, along with several other universities, successfully used a protein called parapinopsin to turn off brain circuits. This protein is found in lamprey - an ancient lineage of jawless fish similar to eel. Reserachers said the ability to inhibit neurons could eventually lead to turning off mood disorders and unwanted behaviors like depression and addiction.
"We found a particular protein that comes from lamprey that has been around for hundreds of millions of years. We took the gene from that protein and found we can control the way neurons talk to each other, which is how chemicals are transmitted into the brain," said lead corresponding author Michael Bruchas, professor of anesthesiology and pain medicine at the University of Washington School of Medicine and co-director of the Imaging and Neural Circuits core of the Center for Neurobiology of Addiction, Pain, and Emotion.
For decades, neuroscientists have been using different types of light-sensitive proteins that are expressed in plants and bacteria to experiment with brain circuitry, said Bruchas. But this is the first time a protein was taken from lamprey to control brain circuits.
Parapinopsin is a type of protein called a "g protein coupled receptor" or GPCR. These GPCRs emerged early on in evolution and can be found in organisms ranging from bacteria to humans. Bruchas said there at least 850 of these kinds of proteins in mammals. These proteins control everything from heart rate to fat storage, to reward and stress responses. GPCRs also respond well to chemicals, such as dopamine and serotonin, which make people feel good.
"Some of these GPCR pathways are highly conserved across millions of years of evolution, and that allowed us to hack into them using parapinopsin," said Bryan Copits, lead author and co-corresponding author, assistant professor of anesthesiology in the Pain Center at Washington University School of Medicine, where Dr. Bruchas was formerly located. Researchers from University of California (UC), Los Angeles, UC Davis, UC San Diego, and University of Zurich were also involved.
The Bruchas Lab focuses on GPCRs. But finding a way to inhibit neurons had been hard to come by until the parapinopsin discovery, Bruchas said.
The researchers found that the protein in lamprey respond to light not chemicals - another approach for targeted delivery. For example, if a part of the brain was having seizures from Parkinson's, it might be possible to isolate the effect with an electrode, dampen it with adjustments to neurotransmission, or to inhibit specific pathways to improve mood.
Bruchas said the original discovery of parapinopsin was made by researchers in Japan in the Terakita lab, who have been discovering different light-sensitive GPCRs across species.
"This is a perfect rationale for why basic science is so incredibly important," said Bruchas. "Because of someone's hard work of basic biological discovery, we have a new tool for medical research. "
Bruchas said his team is planning to use the discovery for research into expanding their knowledge of the inner workings of the brain and to identify treatments for stress, depression, addiction, and pain.
INFORMATION:
This work was funded by the National Institutes of Health Brain Initiative, National Institute of Mental Health, and National Institute of Drug Abuse. Grant numbers: R01 MH111520; NIH R21 DA049569, K01 DA042219, K01 DK115634, T32DA007278, P30DA048736, and R35 GM122577.
Study in brief:
Optical approaches to inhibit neuronal projections rapidly and reversibly have lagged behind those for activation. Copits and others. identify a photoswitchable GPCR-based opsin that couples to inhibitory effectors. This opsin leverages the natural ability of presynaptic GPCRs to inhibit transmitter release to provide an alternative strategy to manipulate distinct synaptic projections.
BUFFALO, N.Y. - Americans are in chronic pain, and a comprehensive new study exploring trends in this major public health concern reveals that what has been a long-standing and under-acknowledged problem is getting substantially worse.
The findings, published in the latest issue of the journal Demography, suggest blanket increases across multiple measures, with pain rising in every adult age group, in every demographic group, and at every site of pain for which data exists. People today are experiencing more pain than individuals of the same age in earlier decades. In fact, each subsequent birth group is in greater pain than the one that came before it.
"We ...
BOSTON - It's a real-life plot worthy of a classic spy novel: Researchers at Massachusetts General Hospital (MGH), the Dana-Farber Cancer Institute and other Boston-area research centers are turning the tables on glioblastomas, the most devastating and aggressive form of brain cancer, by transforming a type of cell that normally protects tumors and inhibits effective drug therapy into a stone-cold glioblastoma killer.
Glioblastoma, a type of brain tumor, is rapidly fatal: Most patients die within two years of diagnosis despite aggressive therapies such as brain surgery, whole-brain radiation and chemotherapy.
Despite hopes that a class of drugs known as immune checkpoint blockers (ICBs) - drugs that have revolutionized the treatment ...
DURHAM, N.C. -- With mosquito season upon us, people are stocking up on repellents to prevent itchy bites. Bug repellents are important because they don't just protect against the buzzing, blood-sucking little pests -- they also safeguard against the diseases they carry, which kill some 700,000 people worldwide each year.
Surprisingly, despite widespread use, no one understood exactly how most mosquito repellents keep the insects away. Now researchers are starting to uncover the first pieces of the puzzle.
A new study has identified a scent receptor in mosquitoes that helps them sniff out and avoid trace amounts of pyrethrum, a plant extract used for centuries to repel biting insects.
One ...
INFORMS Journal Manufacturing & Service Operations Management Study Key Takeaways:
The study looked at archival data on 240 U.S. federal government technology programs across 24 federal agencies.
Researchers found that the practice of moving baseline targets is a key driver in continually increasing budgets for federal government technology programs.
The componentization of a program into smaller work units and increasing the level of competency in program management can dampen this increase, resulting in significant cost savings.
CATONSVILLE, MD, May 11, 2021 ...
HERSHEY, Pa. -- Over the past year, studies have revealed that certain pre-existing conditions, such as cancer, diabetes and high blood pressure, can increase a person's risk of dying from COVID-19. New research shows that individuals living with human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) -- an estimated 38 million worldwide, according to the World Health Organization -- have an increased risk of SARS-CoV-2 infection and fatal outcomes from COVID-19.
In a new study, published in Scientific Reports, Penn State College of Medicine researchers found that people living ...
A newly described horned dinosaur that lived in New Mexico 82 million years ago is one of the earliest known ceratopsid species, a group known as horned or frilled dinosaurs. Researchers reported their find in a publication in the journal PalZ (Paläontologische Zeitschrift).
Menefeeceratops sealeyi adds important information to scientists' understanding of the evolution of ceratopsid dinosaurs, which are characterized by horns and frills, along with beaked faces. In particular, the discovery sheds light on the centrosaurine subfamily of horned dinosaurs, of which Menefeeceratops is believed to be the oldest member. Its remains offer a clearer picture of the group's evolutionary path ...
Researchers have developed a global earthquake monitoring system that uses the Global Navigational Satellite System (GNSS) to measure crustal deformation.
The monitoring system within seconds can rapidly assess earthquake magnitude and fault slip distribution for earthquakes of magnitude 7.0 and larger, making it a potentially valuable tool in earthquake and tsunami early warning for these damaging events, Central Washington University geophysicist Timothy Melbourne and colleagues report in the Bulletin of the Seismological Society of America.
GNSS can potentially characterize a large earthquake much more rapidly than the global seismic network, ...
Covid-19 patients who receive oxygen therapy or experience fever show reduced gray matter volume in the frontal-temporal network of the brain, according to a new study led by researchers at Georgia State University and the Georgia Institute of Technology.
The study found lower gray matter volume in this brain region was associated with a higher level of disability among Covid-19 patients, even six months after hospital discharge.
Gray matter is vital for processing information in the brain and gray matter abnormality may affect how well neurons function and communicate. The study, published in the May 2021 issue of Neurobiology ...
A new approach to road safety that relies on design and engineering principles--the "Safe System" approach--could lead to dramatic reductions in vehicle-related deaths and injuries if implemented in the U.S., according to a report from a consortium of experts convened by researchers at Johns Hopkins Bloomberg School of Public Health and the Institute of Transportation Engineers.
The Safe System approach engineers road systems so that they are safe when used intuitively, the way people tend to use them. A Safe System minimizes the chances for mistakes by drivers, pedestrians, and bicyclists, and reduces the intensity ...
Marie-Claude Bourgeois-Daigneault and her team at the CRCHUM are using mice to show how a combination of peptides and oncolytic viruses, used as an adjuvant, can provide effective immunization against cancer.
In her laboratoryat the University of Montreal Hospital Research Centre (CRCHUM), Marie-Claude Bourgeois-Daigneault and a team of scientists usually modify viruses to make them specific to the cells of a tumour.
Once in the patient's body, these viruses, called oncolytic viruses, infect and specifically destroy the cancer cells without touching healthy cells. These viruses can even stimulate the immune system so that it is better armed to recognize and kill malignant cells. This is immunotherapy.
In a study published in Nature Communications, the scientific team at the University ...
